Literature DB >> 19956859

The ubiquitin-like molecule interferon-stimulated gene 15 is overexpressed in human prostate cancer.

Hirofumi Satake1, Kenji Tamura, Mutsuo Furihata, Takashi Anchi, Hatsune Sakoda, Chiaki Kawada, Tatsuo Iiyama, Shingo Ashida, Taro Shuin.   

Abstract

To identify molecules to serve as diagnostic markers for high-grade prostate cancer (PC) and targets for novel therapeutic drugs, we investigated the gene expression profiles of high-grade PCs using a cDNA microarray combined with laser microbeam microdissection. We subsequently confirmed that the ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) was expressed exclusively in high-grade PCs with high Gleason scores. Semi-quantitative reverse transcription PCR and immunohistochemical analysis confirmed the overexpression of ISG15, a 165 amino acid interferon-inducible ubiquitin-like protein, specifically in high-grade PCs with high Gleason scores 8-9, while it was not expressed in the normal prostate. Immunohistochemical analysis using anti-ISG15 polyclonal antibody confirmed an elevated expression of ISG15 protein in high-grade PCs as well as low-grade PCs compared with that in normal prostate (NP) epithelium. Knockdown of ISG15 expression by short interfering RNA (siRNA) in a PC cell line resulted in marked attenuation of PC cell survival; concordantly, ISG15 overexpression in a PC cell line promoted PC cell growth, indicating its oncogenic property. These findings suggest that ISG15 is involved in cell growth and survival of PCs and that it could be a potential molecular target for new therapeutics and a diagnostic biomarker for human PCs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19956859

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  26 in total

1.  Essential role of JunD in cell proliferation is mediated via MYC signaling in prostate cancer cells.

Authors:  Bethtrice Elliott; Ana Cecilia Millena; Lilya Matyunina; Mengnan Zhang; Jin Zou; Guangdi Wang; Qiang Zhang; Nathan Bowen; Vanessa Eaton; Gabrielle Webb; Shadyra Thompson; John McDonald; Shafiq Khan
Journal:  Cancer Lett       Date:  2019-02-11       Impact factor: 8.679

2.  SNRPE is involved in cell proliferation and progression of high-grade prostate cancer through the regulation of androgen receptor expression.

Authors:  Takashi Anchi; Kenji Tamura; Mutsuo Furihata; Hirofumi Satake; Hatsune Sakoda; Chiaki Kawada; Maiko Kamei; Tsutomu Shimamoto; Hideo Fukuhara; Satoshi Fukata; Shingo Ashida; Takashi Karashima; Ichiro Yamasaki; Masaharu Yasuda; Masayuki Kamada; Keiji Inoue; Taro Shuin
Journal:  Oncol Lett       Date:  2011-12-01       Impact factor: 2.967

Review 3.  Interferon-stimulated gene 15 and the protein ISGylation system.

Authors:  Dongxian Zhang; Dong-Er Zhang
Journal:  J Interferon Cytokine Res       Date:  2010-12-29       Impact factor: 2.607

4.  Long non-coding RNA SNHG6 is upregulated in prostate cancer and predicts poor prognosis.

Authors:  Youji Yan; Zhongjun Chen; Yu Xiao; Xinghuan Wang; Kaiyu Qian
Journal:  Mol Biol Rep       Date:  2019-03-25       Impact factor: 2.316

5.  ERK and AKT signaling drive MED1 overexpression in prostate cancer in association with elevated proliferation and tumorigenicity.

Authors:  Feng Jin; Shazia Irshad; Wei Yu; Madesh Belakavadi; Marina Chekmareva; Michael M Ittmann; Cory Abate-Shen; Joseph D Fondell
Journal:  Mol Cancer Res       Date:  2013-03-28       Impact factor: 5.852

6.  Prognostic value of ISG15 mRNA level in drinkers with esophageal squamous cell cancers.

Authors:  Jun Tao; Ping Hua; Jing Wen; Yi Hu; Hong Yang; Xuan Xie
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

7.  Telomere length influences cancer cell differentiation in vivo.

Authors:  Kyotaro Hirashima; Toshiro Migita; Shigeo Sato; Yukiko Muramatsu; Yuichi Ishikawa; Hiroyuki Seimiya
Journal:  Mol Cell Biol       Date:  2013-05-28       Impact factor: 4.272

8.  Cell type-dependent regulation of free ISG15 levels and ISGylation.

Authors:  Angeles C Tecalco Cruz; Karen Mejía-Barreto
Journal:  J Cell Commun Signal       Date:  2017-03-11       Impact factor: 5.782

9.  Role of opiorphin genes in prostate cancer growth and progression.

Authors:  Amarnath Mukherjee; Augene Park; Li Wang; Kelvin P Davies
Journal:  Future Oncol       Date:  2021-02-17       Impact factor: 3.404

10.  PCA3 noncoding RNA is involved in the control of prostate-cancer cell survival and modulates androgen receptor signaling.

Authors:  Luciana Bueno Ferreira; Antonio Palumbo; Kivvi Duarte de Mello; Cinthya Sternberg; Mauricio S Caetano; Felipe Leite de Oliveira; Adriana Freitas Neves; Luiz Eurico Nasciutti; Luiz Ricardo Goulart; Etel Rodrigues Pereira Gimba
Journal:  BMC Cancer       Date:  2012-11-06       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.